Introduction
============

Antibiotics are essential and abundantly prescribed in hospitals because of their effectiveness and lifesaving benefits. However, the unnecessary use of antibiotics has been observed in earlier studies, and it has persisted as a major issue. Antibiotic overuse, incorrect dosing, and extended duration are some of the leading causes of antibiotic resistance.[@b1-idrt-9-2016-033]--[@b4-idrt-9-2016-033] The increase in antibiotic resistance nowadays is one of the most critical concerns for public health around the world. On the national level, recent articles have demonstrated an increasing pattern of infections with multidrug-resistant organisms in Saudi Arabia, including both gram-positive and gram-negative bacteria.[@b5-idrt-9-2016-033]--[@b7-idrt-9-2016-033] The emerging bacterial resistance to antibiotics is increasing the challenges faced by physicians and institutions.[@b8-idrt-9-2016-033]--[@b10-idrt-9-2016-033] Data on the determinants of the prescription methods of individual physicians in different specialties are limited. Antibiotic prescription by general practitioners in the primary care setting was demonstrated as potentially inappropriate in several studies.[@b11-idrt-9-2016-033]--[@b14-idrt-9-2016-033] There are few studies focusing on inhospital physician behavior and attitudes toward antibiotic use. A recent local study mentioned that general physicians lack consistency in prescription aptitude and the use of practical educational resources; also, they do not strictly follow national and local guidelines. Although the respondents in that study have a clear theoretical knowledge of antimicrobial resistance and careful use of antibiotics,[@b15-idrt-9-2016-033] antibiotic misuse was documented in several studies focusing on the prescription pattern in adult and pediatric patients.[@b16-idrt-9-2016-033]--[@b19-idrt-9-2016-033] In a recent survey in local tertiary care centers, participants were aware of the growing challenge of antimicrobial resistance, but were unaware of the specific antimicrobial resistance rates and patterns in their institutions.[@b20-idrt-9-2016-033] The objective of this study was to further evaluate knowledge and perceptions about antibiotic prescriptions among physicians at our medical centers.

Method
======

This study was conducted at two tertiary care centers in 2015 between August and October, consisting of a cross-sectional survey of noninfectious diseases specialized by physicians. The research was approved by the research committee of King Abdullah International Medical Research Center. Different levels of physicians from several departments, eg, anesthesia, intensive care, internal medicine, surgery, obstetrics/gynecology, emergency medicine, pediatrics, and family medicine, working at King Abdulaziz Medical City and King Saud Medical City in Riyad, Saudi Arabia, were invited to participate. The invitation was sent either by e-mail or SMS messages, targeting all physicians at these two institutions, and participation was voluntary. An online questionnaire, including 25 items, was created in an easy access, smartphone-friendly website. All participants read of the questionnaire type and agreed to the confidentiality conditions before beginning the questionnaire. No personal identifying information was required, and strict confidentiality was maintained. Demographic data including gender, specialty, duration of clinical practice, extra training for infectious diseases, and professional status (intern, resident, senior/chief resident, consultant) were all collated. Other items focused on the physicians' opinions of a problem's magnitude regarding antibiotic resistance were as follows: their knowledge of the local hospital type and the prevalence of antibiotic resistance, their beliefs about the contributors to the development of antibiotic resistance, and their attitudes on useful interventions designed to address the problem. Most questions about beliefs and attitudes used 3- to 6-point Likert-type response options from "useful" to "unuseful," "extremely rare" to "often," and "excellent" to "poor." There were other graded response options such as a 6-point scale that included "not important" to "extremely important." Some questions were also "yes/no" types. To assess the knowledge of antibiotic resistance, physicians were asked to choose the most common resistant organisms at their hospitals, restricted antibiotics at the hospitals that would require a specialist's countersignature, and avoided antibiotics that were more prone to induce antibiotic resistance. Basic knowledge about antibiotic choices in common infections and the best duration of therapy were inquired about along with the factors that would influence their antibiotic choices. The participants were then asked to grade their current knowledge about antibiotic resistance and state whether they needed to improve it or not. Using Microsoft Excel 2011, data were collected and analyzed; all data were collected using the Statistical Product and Service Solutions software, versions 8 and 9 (SPSS Inc.).

Result
======

A total of 200 invitations were sent to the physicians at both institutions, with a response rate of 54%. Among 107 returned questionnaires, 93 were complete and valuable. The sample included 86 internal medicine physicians, who represented 93% of the responders; 21 (23%) consultants, 29 (31%) senior residents, 37 (40%) junior residents, and 6 (6%) interns were also included. Most (67) of the participants were male (72%), and more than half of them were relatively new to clinical practice (less than four years; [Table 1](#t1-idrt-9-2016-033){ref-type="table"}).

Most respondents (82%) perceived antibiotic resistance to be a critical problem globally, and 78% also thought that it is a very important national problem. These attitudes did not differ across specialties or levels of training. About 20% believed that the magnitude of this issue was similar in their institutions when compared to global reports. More than two-thirds of the participants were able to identify the most common resistant organisms in the institution correctly (ie, multidrug-resistant *Pseudomonas aeruginosa*, extended-spectrum beta-lactamase (ESBL)-producing *Escherichia coli*, ESBL-producing *Klebsiella pneumoniae*, and methicillin-resistant *Staphylococcus aureus*; [Tables 2](#t2-idrt-9-2016-033){ref-type="table"} and [3](#t3-idrt-9-2016-033){ref-type="table"}). Participants believed that the widespread use and inappropriate empiric choice of antibiotics were the most important general causes of antibiotic resistance. More than half of the physicians think other elements as being very important causes of antibiotic resistance such as inadequate hand washing, lack of guidelines on antibiotic usage, duration of antibiotic therapy, prescribing unneeded broad-spectrum antibiotics, inadequate restrictions on antibiotic prescribing, and poor access to information on local antibiotic resistance patterns. The role of pharmaceutical companies in advertising and promoting the use of antibiotics, patient expectations, the use of antibiotics in the livestock industry, and random mutations in microbes were not identified by the participants as major factors causing antibiotic resistance ([Table 4](#t4-idrt-9-2016-033){ref-type="table"}).

The beliefs of the screened physicians with regard to the effectiveness of informational interventions that they think are the most useful ways to improve the prescription pattern and decrease antibiotic resistance are local specific guidelines for use of antibiotics, ongoing educational programmes on appropriate antibiotic use, and improving access to updated local antibiotic resistance profiles. The responses of the physicians regarding the usefulness of other possible interventions differed ([Table 5](#t5-idrt-9-2016-033){ref-type="table"}).

With some variation in the indicated duration of therapy with bacterial infections, most of the participants choose to provide long treatment periods (14 days or more) to patients with bloodstream infections and hospital-acquired infections. Approximately 59% and 37% of the physicians think that 7 to 10 days are optimal for treating community-acquired pneumonia and urinary tract infections, respectively, while 23% and 25% think that five days are enough. Around half of the physicians believe that using particular antibiotics, such as ceftriaxone, ciprofloxacin, amoxicillin-clavulanate, and piperacillin-tazobactam, are more likely to induce the development of antibiotic resistance when compared to other classes of antibiotics.

Complications due to infection with resistant organisms were acknowledged by almost all of the participants, with some difference in their estimation of how often these would occur. The main complications recognized were prolonged hospital stays and increased costs of hospitalization, but a few mentioned organ failure and death ([Table 6](#t6-idrt-9-2016-033){ref-type="table"}).

Although most of the participants have a good awareness of their hospital antibiotic restriction policy and the need for infectious disease specialist approval, some of these physicians are clearly unfamiliar with this policy and the names of restricted antibiotics. Notably, 70% were aware that ceftriaxone is not restricted, while 81% were aware that meropenem is a restricted antibiotic that needs specialist approval. The responders believed that the current level of antimicrobial restriction should be maintained at 17% or further increased to 60%.

Approximately two-thirds of the participants assumed that their present knowledge of antibiotics and antibiotic resistance is between average and good, but almost all of them (92%) preferred having a refresher course on antibiotics and the recent guidelines. Upon asking the participants about their first-choice antibiotic for common bacterial infections, they choose amoxicillin--clavulanate (46%) or ceftriaxone (31%) for treating community-acquired pneumonia. In treating urinary tract infection, most physicians preferred using ciprofloxacin (36%), ceftriaxone (18%), or Bactrim (16%), while more than 57% chose piperacillin--tazobactam to treat ventilator-associated pneumonia. Variable results were noted in treating surgical wound infections, and the main choices were amoxicillin--clavulanate, piperacillin--tazobactam, or ceftriaxone. One-third preferred to use piperacillin--tazobactam for intra-abdominal sepsis, followed by meropenem and metronidazole.

Half of the physicians in our survey expected a microbiological definition of the organism and its sensitivity in 3 days or less. They are most likely going to change the antibiotic according to the microbiology report even if the patient is clinically improving. As many as 60% of the physicians will de-escalate the antibiotic based on the sensitivity pattern to a narrower spectrum, if possible ([Table 7](#t7-idrt-9-2016-033){ref-type="table"}).

Discussion
==========

Our survey confirms that physicians are conscious and aware of the issue of antibiotic resistance in the inpatient setting, locally and around the world. They were also mostly aware of the specific resistant organisms and their institutions but not cognizant of their rates and revisions, despite the availability of antibiograms of both. This may indicate that personal experience with antibiotic resistance was the most likely reason for perceptions about importance.

Widespread antibiotic use and inappropriate empirical choices were believed to be important general causes of resistance to 81% of the participants, and on the other side, only half of them thought that antibiotic restriction is a useful intervention to decrease antibiotic resistance. Interestingly, it showed an apparent discrepancy in their estimation. The moderate approval of poor hand hygiene as a critical cause of antibiotic resistance may reflect a need for the awareness of the usefulness of this simple practice. It was noted that physicians are not exposed to nonclinical causes of antibiotic resistance like the basic bacterial mechanism of resistance and the use of antibiotics in the livestock industry. All of these risk factors of developing antimicrobial resistance that are mentioned in [Table 4](#t4-idrt-9-2016-033){ref-type="table"} were identified as carrying the risk of the emergence and spread of resistant bacteria, including those capable of causing infections in both animals and people.[@b4-idrt-9-2016-033],[@b21-idrt-9-2016-033]

According to IDSA guidelines, patients with uncomplicated urinary tract infections or community-acquired pneumonia should be treated for a minimum of 5 days[@b22-idrt-9-2016-033],[@b23-idrt-9-2016-033] and those with bacteremia should be treated for a minimum of 7--10 days,[@b24-idrt-9-2016-033] which showed that the physician tends to use antimicrobials for a longer duration than recommended. According to multiple reports, the extensive use of third-generation cephalosporin antibiotics is developing more resistant bacteria (mainly ESBLs). Also, some interventions showed that discouraging the use of ceftriaxone and ceftazidime will reduce the rate of ESBL bacteria.[@b25-idrt-9-2016-033]--[@b27-idrt-9-2016-033] About half of the participants seem to have an idea about this concept, which is acceptable for the nonspecialized physician. The response of the physicians after the microbiological identification and the susceptibility pattern showed that we have great room for improvement, as one-third of them would not replace the empirical antibiotic for a narrower spectrum.

Although an earlier article stated that physician education has a weak effect in changing physician practice and behavior,[@b28-idrt-9-2016-033] others proved that a multifaceted approach could be successful.[@b29-idrt-9-2016-033]--[@b32-idrt-9-2016-033] Our participants addressed this point, as well as the need for further training and a regular educational program, to improve their antibiotic prescription practice. It is necessary that the informational intervention is accompanied by practical implementations such as computerized physician order entry; this will help increase acceptance by clinicians and will sustain the effectiveness of positive changes. A few studies showed that consulting infectious diseases specialty is important to reduce inappropriate antimicrobial therapy; it improves outcomes and reduces the risk of resistance.[@b33-idrt-9-2016-033]--[@b35-idrt-9-2016-033] This consultation service is usually available and active in the reference hospitals, and it should be utilized.

Our study focused on physicians' attitudes on antibiotic resistance in the inpatient setting and provided additional information to the previous work. To minimize potential bias, we opened our survey in a neutral manner and ensured complete respondent confidentiality. Infectious diseases specialists were excluded from the study, as we were targeting physicians who face common infections. The study limitations included surveying mainly internal medicine physicians, which may make the general data differ from a scenario where surgeons, intensivists, and hematologists, for example, are included as well. The number of the respondents is relatively small compared to the size and capacity of the institutions.

In summary, antimicrobial resistance, globally and nationally, is considered a serious threat, as acknowledged by physicians in this survey. Among the most significant factors is antimicrobial misuse, by either overprescribing or providing inappropriate drugs with some ambivalence, as well as the importance of hand hygiene and antibiotic restrictions. By adhering to local guidelines, continuous education, and other practical interventions, the burden of resistance can be alleviated, as highlighted in this survey.
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###### 

Characteristics of participating physicians.

  VARIABLE                                                 NUMBER (%)
  -------------------------------------------------------- ------------
  Male                                                     67 (72%)
  Female                                                   26 (28%)
  Duration of clinical practice (years)                    
   0--4                                                    52 (56%)
   5--9                                                    25 (27%)
   10--14                                                  5 (6%)
   15--19                                                  4 (4%)
   More than 20                                            7 (7%)
  Professional status                                      
   Consultant                                              21 (22%)
   Senior resident                                         29 (31%)
   Junior resident                                         38 (41%)
   Intern                                                  5 (6%)
  Had extra training in microbiology/infectious diseases   
   Yes                                                     26 (28%)
   No                                                      67 (72%)

###### 

Physicians' opinions of the magnitude of the problem of antibiotic resistance.

  QUESTION                                                                                                                                         NOT IMPORTANT   MINIMALLY IMPORTANT   MODERATELY IMPORTANT   VERY IMPORTANT   EXTREMELY IMPORTANT   DON'T KNOW
  ------------------------------------------------------------------------------------------------------------------------------------------------ --------------- --------------------- ---------------------- ---------------- --------------------- ----------------
  Please circle the number that best describes your opinion of the magnitude of the problem of antibiotic resistance **\[Globally\]**              3 (3%)          5 (5%)                3 (3%)                 36 (39%)         41 (45%)              5 (5%)
  Please circle the number that best describes your opinion of the magnitude of the problem of antibiotic resistance **\[Nationally\]**            3 (3%)          3 (3%)                9 (10%)                28 (30%)         45 (49%)              5 (5%)
  Please circle the number that best describes your opinion of the magnitude of the problem of antibiotic resistance **\[At your institution\]**   5 (5%)          5 (5%)                5 (5%)                 20 (22%)         52 (56%)              6 (7%)
                                                                                                                                                   **MUCH LESS**   **LESS**              **ABOUT SAME**         **MORE**         **MUCH MORE**         **DON'T KNOW**
  How do you think your institution's prevalence of antibiotic resistance compares with first-world (global) figures?                              7 (8%)          15 (16%)              19 (20%)               32 (34%)         8 (9%)                12 (13%)

###### 

Which of the following resistant organisms do you see at your institution? Tick all that apply.

  ORGANISM NAME                                                                    FREQUENCY
  -------------------------------------------------------------------------------- -----------
  Multi-resistant *Pseudomonas aeruginosa*                                         47%
  Multi-resistant *Acinetobacter* sp.                                              59%
  Extended spectrum beta-lactamase producing *Escherichia coli* (ESBL *E. coli*)   69%
  Extended spectrum beta-lactamase producing *Klebsiella pneumoniae*               61%
  Penicillin-resistant *Streptococcus pneumoniae* (PRSP)                           9%
  Methicillin-resistant *Staphylococcus aureus* (MRSA)                             78%
  Vancomycin resistant *Enterococcus* (VRE)                                        47%

###### 

To what extent do you think each of the following contributes to the development of antibiotic resistance?

  CAUSE OF ANTIBIOTIC RESISTANCE                                                                            MINIMALLY IMPORTANT   MODERATELY IMPORTANT   VERY IMPORTANT   DON'T KNOW
  --------------------------------------------------------------------------------------------------------- --------------------- ---------------------- ---------------- ------------
  Widespread use of antibiotics                                                                             3 (3%)                13 (14%)               75 (81%)         2 (2%)
  Inappropriate empiric choice of antibiotics                                                               2 (2%)                23 (25%)               66 (71%)         2 (2%)
  Inappropriate duration of antibiotic therapy                                                              7 (7%)                24 (26%)               61 (66%)         1 (1%)
  Prescribing broad-spectrum antibiotics when equally effective narrow spectrum antibiotics are available   3 (3%)                26 (28%)               59 (64%)         5 (5%)
  Inadequate hand washing                                                                                   15 (16%)              20 (22%)               56 (60%)         2 (2%)
  Inadequate restrictions on antibiotic prescribing                                                         6 (7%)                28 (30%)               54 (58%)         5 (5%)
  Poor access to information on local antibiotic resistance patterns                                        4 (4%)                31 (33%)               51 (55%)         7 (8%)
  Lack of guidelines on antibiotic usage                                                                    7 (8%)                27 (29%)               54 (58%)         5 (5%)
  Random mutations in microbes                                                                              10 (11%)              41 (44%)               24 (26%)         18 (19%)
  Patient demands and expectations for antibiotics                                                          25 (27%)              34 (36%)               25 (27%)         9 (10%)
  Use of antibiotics in the livestock industry                                                              11 (12%)              31 (33%)               14 (15%)         37 (40%)
  Role of pharmaceutical companies in advertising and promoting use of antibiotics                          18 (19%)              32 (34%)               22 (24%)         21 (23%)

###### 

Physician ratings of the usefulness of potential interventions for antibiotic resistance.

  INTERVENTION                                                                          USEFUL     MAY BE USEFUL   NOT USEFUL   DON'T KNOW
  ------------------------------------------------------------------------------------- ---------- --------------- ------------ ------------
  Antibiotic restriction.                                                               46 (50%)   33 (35%)        11 (12%)     3 (3%)
  Regular microbiology consultations/ward round.                                        50 (54%)   31 (33%)        7 (8%)       5 (5%)
  Improving access to up-to-date information on local antibiotic resistance patterns.   65 (70%)   23 (25%)        3 (3%)       2 (2%)
  Ongoing educational program on appropriate antibiotic use.                            67 (73%)   17 (18%)        6 (6%)       3 (3%)
  Antibiotic cycling.                                                                   18 (19%)   46 (49%)        3 (3%)       26 (29%)
  Use of institution-specific guidelines for use of antibiotics for common infection.   69 (74%)   14 (15%)        6 (7%)       4 (4%)

###### 

How often would you say that infections with resistant organisms contributed to the following outcomes?

  COMPLICATION                     EXTREMELY RARE   RARE      SOMETIMES   SOMEWHAT OFTEN   OFTEN      NOT SURE
  -------------------------------- ---------------- --------- ----------- ---------------- ---------- ----------
  Prolonged hospital stay          3 (3%)           3 (3%)    12 (13%)    16 (17%)         57 (61%)   2 (2%)
  Increased hospitalization cost   2 (2%)           7 (8%)    7 (8%)      16 (17%)         57 (61%)   4 (4%)
  Organ failure                    4 (4%)           5 (5%)    27 (29%)    19 (21%)         34 (37%)   4 (4%)
  Death                            8 (9%)           9 (10%)   19 (20%)    17 (18%)         27 (29%)   13 (14%)

###### 

Physicians practice after starting antibiotics.

  QUESTIONS                                                                                                                                                                                           NUMBER (%)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  In general, how long does it take to get results from your microbiology department?                                                                                                                 
  • 0--3 days                                                                                                                                                                                         46 (50%)
  • 4--7 days                                                                                                                                                                                         40 (43%)
  • 1--2 weeks                                                                                                                                                                                        7 (7%)
  In a patient who is responding clinically to current antibiotic therapy, what is your response to a culture report that indicates the organisms isolated are resistant to that antibiotic regime?   
  • I change to appropriate antibiotics based on the report                                                                                                                                           57 (61%)
  • I continue the present antibiotics                                                                                                                                                                29 (31%)
  • I add one of the susceptible antibiotics to the current regime                                                                                                                                    7 (8%)
  If the culture report shows an isolate that is sensitive to my current antibiotics, but also to a narrower-spectrum antibiotic                                                                      
  • I continue present therapy                                                                                                                                                                        35 (38%)
  • I change to the narrow-spectrum antibiotic                                                                                                                                                        58 (62%)
  In your practice, how often would you say that your empiric coverage correlated with susceptibility reports from the microbiology laboratory?                                                       
  • Often                                                                                                                                                                                             15 (16%)
  • Somewhat often                                                                                                                                                                                    35 (38%)
  • Sometime                                                                                                                                                                                          33 (36%)
  • Rarely                                                                                                                                                                                            4 (4%)
  • Extremely rarely                                                                                                                                                                                  1 (1%)
  • Never checked/not sure                                                                                                                                                                            5 (5%)
